eticlopride has been researched along with oxidopamine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (38.10) | 18.2507 |
| 2000's | 9 (42.86) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pollack, AE; Wooten, GF | 2 |
| Zahm, DS | 1 |
| LaHoste, GJ; Marshall, JF | 1 |
| Cole, BN; LaHoste, GJ; Marshall, JF | 1 |
| Cole, DG; Hyman, SE; Kobierski, LA; Konradi, C | 1 |
| Fink, JS; Pollack, AE; Turgeon, SM | 1 |
| Billings, LM; Marshall, JF; Schuller, JJ | 1 |
| Belforte, JE; Murer, MG; Pazo, JH; Riquelme, LA; Tseng, KY | 1 |
| Bardo, MT; Brown, RW; Dwoskin, LP; Green, TA; Phillips, SB | 1 |
| Liang, PJ; Liu, Y; Luo, FJ | 1 |
| El Banoua, F; Fernandez-Espejo, E; Flores, JA; Galán-Rodríguez, B | 1 |
| Marshall, JF; Morrow, J; Trevitt, JT | 1 |
| Bishop, C; Taylor, JL; Walker, PD | 1 |
| Bartell, PA; McIvor, W; Menaker, M; Miranda-Anaya, M | 1 |
| Baucum, AJ; Cook, GA; Fleckenstein, AE; Gibb, JW; Hadlock, GC; Hanson, GR; Horner, KA; King, JL; Wilkins, DG | 1 |
| Cenci, MA; Lindgren, HS; Ohlin, KE | 1 |
| Arai, Y; Kikuchi, T; Mitazaki, S; Nakagawasai, O; Nakaya, K; Niijima, F; Onogi, H; Sato, A; Tadano, T; Tan-No, K | 1 |
| Chang, C; Chen, CC; Shih, YY | 1 |
| Brimijoin, S; Gao, J; Li, Y; Sui, N; Zhu, N | 1 |
| Brazhnik, E; Cruz, AV; McCoy, AJ; Novikov, N; Walters, JR | 1 |
21 other study(ies) available for eticlopride and oxidopamine
| Article | Year |
|---|---|
Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Blotting, Northern; Corpus Striatum; Desipramine; Dopamine; Enkephalins; Ergolines; Gene Expression Regulation; Kinetics; Male; Nucleic Acid Hybridization; Oligonucleotide Probes; Oxidopamine; Protein Precursors; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reference Values; RNA, Messenger; Salicylamides; Stereotaxic Techniques | 1992 |
D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons.
Topics: Acetylcholine; Animals; Blotting, Northern; Corpus Striatum; Dose-Response Relationship, Drug; Enkephalins; Interneurons; Kinetics; Male; Models, Neurological; Nucleic Acid Hybridization; Oligonucleotide Probes; Oxidopamine; Phosphorus Radioisotopes; Protein Precursors; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; RNA, Messenger; Salicylamides; Scopolamine | 1992 |
Subsets of neurotensin-immunoreactive neurons revealed following antagonism of the dopamine-mediated suppression of neurotensin immunoreactivity in the rat striatum.
Topics: Animals; Benzazepines; Calbindins; Caudate Nucleus; Corpus Striatum; Dopamine; Dopamine Antagonists; Haloperidol; Immunohistochemistry; Male; Neurons; Neurotensin; Oxidopamine; Putamen; Rats; Rats, Inbred Strains; S100 Calcium Binding Protein G; Salicylamides | 1992 |
Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis.
Topics: Analysis of Variance; Animals; Apomorphine; Autoradiography; Corpus Striatum; Denervation; Dopamine; Dopamine Agents; Ergolines; Hydroxydopamines; Male; Mazindol; Nucleus Accumbens; Oxidopamine; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Tritium | 1991 |
Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Corpus Striatum; Dopamine Agents; Dopamine D2 Receptor Antagonists; Ergolines; Functional Laterality; Gene Expression; Genes, fos; Globus Pallidus; Male; Oxidopamine; Proto-Oncogene Proteins c-fos; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Substantia Nigra | 1993 |
6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Dopamine; Embryo, Mammalian; Ergolines; Gene Expression; Genes, fos; Levodopa; Male; Neurons; Oxidopamine; Phosphorylation; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Substantia Nigra | 1994 |
Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
Topics: Animals; Apomorphine; Axonal Transport; Basal Ganglia; Benzazepines; Corpus Striatum; Dopamine Agonists; Functional Laterality; Gold Colloid; Male; Models, Neurological; Motor Activity; Neurons; Oxidopamine; Proto-Oncogene Proteins c-fos; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Rotation; Salicylamides; Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 1997 |
Dopaminergic modulation of pallidal preproenkephalin mRNA.
Topics: Animals; Benzazepines; Dopamine; Dopamine Antagonists; Enkephalins; Gene Expression; Globus Pallidus; Male; Neurons; Oxidopamine; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Salicylamides; Substantia Nigra; Sulfur Radioisotopes; Sympatholytics | 1999 |
Substantia nigra pars reticulata units in 6-hydroxydopamine-lesioned rats: responses to striatal D2 dopamine receptor stimulation and subthalamic lesions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Corpus Striatum; Dopamine Antagonists; Kainic Acid; Male; Neurons; Oxidopamine; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Salicylamides; Substantia Nigra; Subthalamic Nucleus | 2000 |
Locomotor stimulant effects of nornicotine: role of dopamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Drug Synergism; Male; Motor Activity; Nicotine; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Salicylamides; Stimulation, Chemical; Sympathectomy, Chemical; Sympatholytics | 2002 |
Dopamine effect on the stimulus pattern related changes in response characteristics of R/G horizontal cells in carp retina.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic Agents; Animals; Carps; Dopamine; Dopamine Antagonists; Drug Interactions; In Vitro Techniques; Light; Membrane Potentials; Neurons; Oxidopamine; Receptors, Dopamine D2; Retina; Salicylamides; Time Factors | 2003 |
Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors.
Topics: Analgesics, Opioid; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Dopamine; Dopamine Antagonists; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Electrochemistry; Heroin; Male; Morphine; Neurons; Oxidopamine; Pain Measurement; Periaqueductal Gray; Phosphopyruvate Hydratase; Rats; Rats, Wistar; Reaction Time; Receptors, Dopamine D1; Salicylamides; Tyrosine 3-Monooxygenase | 2004 |
Dopamine manipulation alters immediate-early gene response of striatal parvalbumin interneurons to cortical stimulation.
Topics: Adrenergic Agents; Animals; Cell Count; Cerebral Cortex; Corpus Striatum; Diagnostic Imaging; Dopamine; Dopamine Antagonists; Drug Interactions; GABA Antagonists; Gene Expression Regulation; Immunohistochemistry; Interneurons; Male; Oncogene Proteins v-fos; Oxidopamine; Parvalbumins; Picrotoxin; Rats; Rats, Sprague-Dawley; Salicylamides; Tyrosine 3-Monooxygenase | 2005 |
Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Dyskinesia, Drug-Induced; Hydroxyindoleacetic Acid; Levodopa; Male; Norepinephrine; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Serotonin | 2005 |
Interactions between dopamine and melatonin organize circadian rhythmicity in the retina of the green iguana.
Topics: Animals; Cell Culture Techniques; Chromatography, High Pressure Liquid; Circadian Rhythm; Dopamine; Dopamine Antagonists; Iguanas; Immunohistochemistry; Melatonin; Oxidopamine; Quinpirole; Retina; Salicylamides | 2007 |
Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
Topics: Animals; Benzazepines; Blotting, Western; Data Interpretation, Statistical; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; In Vitro Techniques; Male; Methamphetamine; Neostriatum; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Sympathectomy, Chemical; Synaptosomes | 2009 |
Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Antiparkinson Agents; Basal Ganglia; Benzazepines; Bromocriptine; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Extracellular Signal-Regulated MAP Kinases; Female; Levodopa; Neovascularization, Pathologic; Oxidopamine; Parkinsonian Disorders; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 2009 |
p-Hydroxyamphetamine causes prepulse inhibition disruptions in mice: contribution of dopamine neurotransmission.
Topics: Animals; Benzazepines; Clozapine; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Indoles; Injections, Intraventricular; Male; Mice; Mice, Inbred Strains; Oxidopamine; p-Hydroxyamphetamine; Piperazines; Piperidines; Pyridines; Pyrroles; Reflex, Startle; Salicylamides; Sensory Gating; Sympathomimetics; Synaptic Transmission | 2010 |
Dopaminergic imaging of nonmotor manifestations in a rat model of Parkinson's disease by fMRI.
Topics: Animals; Blood Volume; Blood Volume Determination; Brain; Cerebrovascular Circulation; Dopamine; Dopamine Antagonists; Ferric Compounds; Functional Laterality; Immunohistochemistry; Magnetic Resonance Imaging; Male; Metal Nanoparticles; Nociceptive Pain; Oxidopamine; Parkinsonian Disorders; Rats, Wistar; Salicylamides; Tyrosine 3-Monooxygenase | 2013 |
Roles of dopaminergic innervation of nucleus accumbens shell and dorsolateral caudate-putamen in cue-induced morphine seeking after prolonged abstinence and the underlying D1- and D2-like receptor mechanisms in rats.
Topics: Animals; Benzazepines; Cues; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug-Seeking Behavior; Male; Morphine; Nucleus Accumbens; Oxidopamine; Putamen; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 2013 |
Functional correlates of exaggerated oscillatory activity in basal ganglia output in hemiparkinsonian rats.
Topics: Action Potentials; Adrenergic Agents; Animals; Antiparkinson Agents; Basal Ganglia; Brain Waves; Disease Models, Animal; Dopamine Antagonists; Functional Laterality; Levodopa; Male; Neural Pathways; Oxidopamine; Parkinsonian Disorders; Piperazines; Pyridines; Rats; Rats, Long-Evans; Salicylamides; Serotonin Antagonists; Substantia Nigra | 2014 |